Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hebert

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
The Pharmacogenomics Journal|May 12, 2016
Prenatal pharmacogenomics: a promising area for researchE H Dorfman, E Y Cheng, M F Hebert, et al.
Molecular Pharmacology|December 15, 2007
The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research StudyLin Zhou, Suresh Babu Naraharisetti, Honggang Wang, et al.
Clinical Pharmacology and Therapeutics|July 1, 1995
The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporineD Y Gomez, V J Wacher, S J Tomlanovich, et al.
The Journal of Biological Chemistry|August 10, 2014
Taste of a pill: organic cation transporter-3 (OCT3) mediates metformin accumulation and secretion in salivary glandsNora Lee, Haichuan Duan, Mary F Hebert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancersK Szepeshazi, A V Schally, G Halmos, et al.
International Journal of Cancer|July 15, 1999
Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238Z Kahán, A Nagy, A V Schally, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 6, 2007
Validation of a sensitive LC-MS assay for quantification of glyburide and its metabolite 4-transhydroxy glyburide in plasma and urine: an OPRU Network studySuresh Babu Naraharisetti, Brian J Kirby, Mary F Hebert, et al.
British Journal of Clinical Pharmacology|May 3, 2016
Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestationShringi Sharma, Steve Caritis, Gary Hankins, et al.
The Prostate|July 6, 2000
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathwaysA Plonowski, A V Schally, J L Varga, et al.
Psychopharmacology|September 16, 2006
Assessment of cognitive function in the heterozygous reeler mouseDilja D Krueger, Jessica L Howell, Britni F Hebert, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
The Pharmacogenomics Journal|May 12, 2016
Prenatal pharmacogenomics: a promising area for researchE H Dorfman, E Y Cheng, M F Hebert, et al.
Molecular Pharmacology|December 15, 2007
The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research StudyLin Zhou, Suresh Babu Naraharisetti, Honggang Wang, et al.
Clinical Pharmacology and Therapeutics|July 1, 1995
The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporineD Y Gomez, V J Wacher, S J Tomlanovich, et al.
The Journal of Biological Chemistry|August 10, 2014
Taste of a pill: organic cation transporter-3 (OCT3) mediates metformin accumulation and secretion in salivary glandsNora Lee, Haichuan Duan, Mary F Hebert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancersK Szepeshazi, A V Schally, G Halmos, et al.
International Journal of Cancer|July 15, 1999
Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238Z Kahán, A Nagy, A V Schally, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 6, 2007
Validation of a sensitive LC-MS assay for quantification of glyburide and its metabolite 4-transhydroxy glyburide in plasma and urine: an OPRU Network studySuresh Babu Naraharisetti, Brian J Kirby, Mary F Hebert, et al.
British Journal of Clinical Pharmacology|May 3, 2016
Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestationShringi Sharma, Steve Caritis, Gary Hankins, et al.
The Prostate|July 6, 2000
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathwaysA Plonowski, A V Schally, J L Varga, et al.
Psychopharmacology|September 16, 2006
Assessment of cognitive function in the heterozygous reeler mouseDilja D Krueger, Jessica L Howell, Britni F Hebert, et al.
Pageof 15